Clinical Trials Logo
  1. Home
  2. Menstrual Migraine
  3. NCT01578941

An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine

Menstrual Migraine Clinical Trial

Clinical Trial Summary

The study is to primarily investigate whether Treximet® (Imitrex RT/naproxen sodium 500mg) taken at the first onset of menstrual migraine will both terminate the acute headache and assist in preventing headache recurrence and the need for repeat abortive therapy over the ensuing days of menses.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01578941
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Completed
Phase Phase 4
Start date January 2011
Completion date September 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT04600388 - Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine
Not yet recruiting NCT03702114 - Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )
Not yet recruiting NCT02592681 - Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine N/A
Completed NCT01329562 - CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet Phase 4
Recruiting NCT06173661 - Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45 Phase 4
Recruiting NCT03152305 - Intracranial Pressure During Migraine N/A
Completed NCT04102995 - A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Phase 2
Terminated NCT01395264 - Saccadometry in Primary Headache Syndromes N/A
Terminated NCT01114711 - Frovatriptan and Menstrual Migraine